Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dacomitinib in Advanced Penile Squamous Cell Carcinoma
NCT01728233Phase 2Completed
- Sponsor
- Fondazione IRCCS - Istituto Nazionale dei Tumori di Milano
- Start
- Jun 2013
- Primary completion
- Sep 2018
- Modality
- Fragment-Derived Small Molecules, Allosteric Modulators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of dacomitinib in penile squamous cell carcinoma (PSCC), sponsored by Fondazione IRCCS - Istituto Nazionale dei Tumori di Milano. Started Jun 2013; status: completed.
02
Drugs
dacomitinib
03
Conditions
penile squamous cell carcinoma (PSCC)
Beyond the preview
Go deeper on NCT01728233.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01728233.